Europe Hypertrophic and Keloid Scar Treatment Market to Grow at a CAGR of 10.1% to reach US$ 2,705.59 million from 2020 to 2027

The hypertrophic and keloid scar treatment market in Europe is expected to grow from US$ 1,376.88 million in 2020 to US$ 2,705.59 million by 2027; it is estimated to grow at a CAGR of 10.1% from 2020 to 2027.

The UK, Germany, and France are major economies in Europe. Growing cases of injuries is the major factor driving the growth of the Europe hypertrophic and keloid scar treatment market. Injuries and their extension deep into the dermis are the major cause of hypertrophic and keloids scars. Injuries can be further classified as scratches, burns, cuts, gashes, sutures, surgical incisions, and so on. The prevalence rate of injuries ultimately converting to a keloid or hypertrophic scars is 5–15%. In addition, skin conditions such as acne and dark pigmentation also lead to hypertrophic and keloid scar development. The cases of different types of injuries are commonly seen among all age groups. Acne, sports injuries, and road accidents are more common among youngsters. Acne is also a common problem among middle-aged people, irrespective of their gender. The hormonal imbalance among people leads to acne, which might leave severe scars on skin. Acne is estimated to be affecting ~10% of the total global population. According to the WHO data published in February 2020, road accident-led injuries are the leading cause of death among young adults aged 5–29. ~1.35 million fatalities are registered per year due to road accidents. However, the rate of severe injuries by road accidents is also rising. Therefore, the increasing number of accidents is indirectly leading to the rising demand for hypertrophic and keloid scar treatments, which is further anticipated to drive the market in Europe.

Spain, Italy, Germany, France, and the UK are the most affected countries in Europe, owing to the increasing number of COVID-19 cases and deaths. As per the Worldometer, in Spain, Italy, Germany, France, and the UK, the number of cases is 2.25 million, 2.37 million, 2 million, 95 million, 3.36 million, respectively. The number of deaths in these countries is also high. As per the news article, in Italy, due to the COVID-19 emergency, access for thousands of cancer patients in need of chemotherapy, scans, transplants, and surgery has become difficult. There is several issued guidance from national and international organizations trying to help cope with suspected or verified COVID-19 patients. Besides, Germany has prolonged its pandemic prohibitions, including closing schools and shops, until mid-February due to fears that new COVID-19 mutations could cause a further increase in cases. In addition to extending the closing of restaurants, shops, and schools until February 14, Merkel and the governors of Germany's 16 states decided to enable citizens to wear more functional FFP2 or KN95 masks on public transport and supermarkets. Employers would now be ordered to encourage workers to work from home, wherever possible, to prevent office-driven infections. Hypertrophic and keloid scar treatment patients are considered less sensitive from COVID-19 than the general population. Europe has long been within an area of dynamic development in dermatology procedures, adapting to different cultures, traditions, and surgical and medical philosophies. In recent times, these changes have been even more significant and rapid.

Get more information on this report :

Europe Hypertrophic and Keloid Scar Treatment Market Segmentation

Europe Hypertrophic and Keloid Scar Treatment Market – By Scar Type

Hypertrophic
Keloid

Europe Hypertrophic and Keloid Scar Treatment Market – By Product Type

Injectables
Topical
- Gels
- Silicone Sheets
- Creams
- Other
Laser
- CO2
- Pulse-Dyed
- Other
Other

Europe Hypertrophic and Keloid Scar Treatment Market – By End User

Hospitals
Clinics
Homecare

Europe Hypertrophic and Keloid Scar Treatment Market, by Country

Germany
UK
France
Italy
Spain
Rest of Europe

Europe Hypertrophic and Keloid Scar Treatment Market-Companies Mentioned

Alliance Pharma PLC
HRA Pharma
Mölnlycke Health Care AB.
Newmedical Technology Inc.
Perrigo Company plc
Lumenis
Smith & Nephew
Sonoma Pharmaceuticals, Inc
Suneva Medical

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Hypertrophic and Keloid Scar Treatment Market – By Scar Type

1.3.2 Europe Hypertrophic and Keloid Scar Treatment Market – By Product Type

1.3.3 Europe Hypertrophic and Keloid Scar Treatment Market – By End User

1.3.4 Europe Hypertrophic and Keloid Scar Treatment Market – By Country

2. Europe Hypertrophic and Keloid Scar Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Hypertrophic and Keloid Scar Treatment Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Expert Opinion

5. Europe Hypertrophic and Keloid Scar Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Benefits of Laser Treatment

5.1.2 Growing Cases of Injuries

5.2 Market Restraints

5.2.1 Unavailability of Universal Treatment Due to Huge Costs, Side Effects, and Scanty Awareness

5.3 Market Opportunities

5.3.1 Tapping Market in Emerging Countries

5.4 Future Trends

5.4.1 Arising Treatments Modalities

5.5 Impact Analysis

6. Hypertrophic and Keloid Scar Treatment Market – Europe Analysis

6.1 Europe Hypertrophic and Keloid Scar Treatment Market Revenue Forecast and Analysis

7. Europe Hypertrophic and Keloid Scar Treatment Market– By Scar Type

7.1 Overview

7.2 Europe Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

7.3 Hypertrophic

7.3.1 Overview

7.3.2 Hypertrophic: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

7.4 Keloid

7.4.1 Overview

7.4.2 Keloid: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8. Europe Hypertrophic and Keloid Scar Treatment Market– By Product Type

8.1 Overview

8.2 Europe Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

8.3 Laser Products

8.3.1 Overview

8.3.2 Laser Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.1 CO2 Market

8.3.2.1.1 Overview

8.3.2.1.2 CO2 Market: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.2 Pulse-Dyed Market

8.3.2.2.1 Overview

8.3.2.2.2 Pulse-Dyed Market: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.3 Other Laser Products Market

8.3.2.3.1 Overview

8.3.2.3.2 Other Laser Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4 Topical Products

8.4.1 Overview

8.4.2 Topical Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.1 Creams Market

8.4.2.1.1 Overview

8.4.2.1.2 Creams: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.2 Gels Market

8.4.2.2.1 Overview

8.4.2.2.2 Gels: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.3 Silicone Sheets Market

8.4.2.3.1 Overview

8.4.2.3.2 Silicone Sheets: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.4 Other Topical Products Market

8.4.2.4.1 Overview

8.4.2.4.2 Others Topical Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.5 Injectables

8.5.1 Overview

8.5.2 Injectables: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.6 Other Products

8.6.1 Overview

8.6.2 Other Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9. Europe Hypertrophic and Keloid Scar Treatment Market– By End User

9.1 Overview

9.2 Europe Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.5 Homecare

9.5.1 Overview

9.5.2 Homecare: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

10. Europe Hypertrophic and Keloid Scar Treatment Market – Country Analysis

10.1 Europe: Hypertrophic and Keloid Scar Treatment Market

10.1.1 Overview

10.1.2 Europe: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

10.1.3 Germany: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1 Germany: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2 Germany: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.3.3 Germany: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.3.3.1 Germany: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.3.3.2 Germany: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.3.4 Germany: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.4 UK: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1 UK: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2 UK: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.4.3 UK: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.4.3.1 UK: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.4.3.2 UK: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.4.4 UK: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.5 France: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1 France: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2 France: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.5.3 France: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.5.3.1 France: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.5.3.2 France: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.5.4 France: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.6 Spain: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1 Spain: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2 Spain: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.6.3 Spain: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.6.3.1 Spain: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.6.3.2 Spain: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.6.4 Spain: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.7 Italy: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1 Italy: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2 Italy: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.7.3 Italy: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.7.3.1 Italy: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.7.3.2 Italy: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.7.4 Italy: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.8 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.8.3 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.8.3.1 Rest of Europe: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.8.3.2 Rest of Europe: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.8.4 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

11. Impact Of COVID-19 Pandemic On Europe Hypertrophic and Keloid Scar Treatment Market

11.1 Europe: Impact Assessment Of COVID-19 Pandemic

12. Europe Hypertrophic and Keloid Scar Treatment Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. COMPANY PROFILES

13.1 Alliance Pharma PLC

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Mölnlycke Health Care AB.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Smith & Nephew

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Newmedical Technology Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5.5 Sonoma Pharmaceuticals, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Suneva Medical

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 HRA Pharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Lumenis

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Perrigo Company plc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Table 2. Germany: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 3. Germany: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 4. Germany: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5. Germany: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6. Germany: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7. UK: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 8. UK: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 9. UK: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10. UK: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. UK: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 12. France: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 13. France: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 14. France: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15. France: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16. France: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17. Spain: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 18. Spain: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 19. Spain: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 20. Spain: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 21. Spain: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 22. Italy: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 23. Italy: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 24. Italy: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 25. Italy: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 26. Italy: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 27. Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 28. Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 29. Rest of Europe: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 30. Rest of Europe: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 31. Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 32. Organic Developments Done By Companies

Table 33. Inorganic Developments Done By Companies

Table 34. Glossary of Terms, Europe Hypertrophic and Keloid Scar Treatment Market

LIST OF FIGURES

Figure 1. Europe Hypertrophic and Keloid Scar Treatment Market Segmentation

Figure 2. Europe Hypertrophic and Keloid Scar Treatment Market, By Country

Figure 3. Europe Hypertrophic and Keloid Scar Treatment Market Overview

Figure 4. Hypertrophic Segment Held Largest Share of Scar Type Segment In Europe Hypertrophic and Keloid Scar Treatment Market

Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Europe PEST Analysis

Figure 7. Expert Opinion

Figure 8. Europe Hypertrophic and Keloid Scar Treatment Market Impact Analysis of Drivers and Restraint

Figure 9. Europe Hypertrophic and Keloid Scar Treatment Market – Revenue Forecast And Analysis – 2019- 2027

Figure 10. Europe Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

Figure 11. Hypertrophic: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 12. Keloid: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 13. Europe Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

Figure 14. Laser Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 15. CO2 Market: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 16. Pulse-Dyed Market: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 17. Other Laser Products Market: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 18. Topical Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 19. Creams: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 20. Gels: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 21. Silicone Sheets: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 22. Other Topical Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 23. Injectables: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 24. Other Products: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 25. Europe Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

Figure 26. Hospitals: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 27. Clinics: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 28. Homecare: Europe Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 29. Europe: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)

Figure 30. Europe: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

Figure 31. Germany: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. UK: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 33. France: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 34. Spain: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 35. Italy: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 36. Rest of Europe: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 37. Impact of COVID-19 Pandemic In European Country Markets

Alliance Pharma PLC
HRA Pharma
Mölnlycke Health Care AB.
Newmedical Technology Inc.
Perrigo Company plc
Lumenis
Smith & Nephew
Sonoma Pharmaceuticals, Inc
Suneva Medical

To understand the Europe hypertrophic and keloid scar treatment market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe hypertrophic and keloid scar treatment market
Efficiently plan M&A and partnership deals in Europe hypertrophic and keloid scar treatment market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe hypertrophic and keloid scar treatment market
Obtain market revenue forecast for market by various segments from 2020-2027 in Europe region.

Report Code

TIPRE00025197

Full Name

Phone Number

Country

Company

Job Title

Comment

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Excel Datapack $2000
Single User License
$3000 $2400
Site license
$4000 $3200
Enterprise License
$5000 $4000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Report name	Published Month	Price
Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others), Cancer Type (Astrocytoma, Glioblastoma Multiforme, Ependymomas, and Others), and End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others); and Geography	Publication Month: Sep 2021	$4550	GET SAMPLE PDF
Remote Cardiac Monitoring Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Devices, Software and Services); End User (Hospitals and Clinics, Emergency Settings, Homecare Settings and Others), and Geography	Publication Month: Sep 2021	$4550	GET SAMPLE PDF
Sports Mouthguard Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Stock Mouthguard, Boil and Bite Mouthguard, Custom Made Mouthguard, Smart Mouthguards); Distribution Channel (Offline, Online), and Geography.	Publication Month: Aug 2021	$4550	GET SAMPLE PDF
Pediatric MRI Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type [Functional Brain MRI (fMRI), Cardiac MRI, 4D MRI, and Others], Application (Neurology, Orthopedics, Cardiology, Oncology, and Others), and End User (Hospitals, Diagnostic Centers, and Others)	Publication Month: Aug 2021	$4550	GET SAMPLE PDF
Microbial Air Sampler Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Portable Microbial Air Sampler, Desktop Microbial Air Sampler, and Accessories), Collection Technique (Impact Air Sampler, Impinge Air Sampler, Surface Air Sampler, Compressed Air Sampler, Real-Time Sampler, and Others), Connectivity (Mobile Satellite Services and Fixed Satellite Services), End Users (Research and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Food and Beverage, Personal Care Industries, and Others), and Distribution Channel (Direct Tender, Retail Sales, Third-Party Distributor, and Others)	Publication Month: Aug 2021	$4550	GET SAMPLE PDF

+1-646-491-9876 , +91-20-67271632 sales@theinsightpartners.com

Europe Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, Other Products), and End User (Hospitals, Clinics, and Homecare)